ACT artemisinin-combination therapy
AIDS acquired immune deficiency syndrome
AMC advance market commitment
AMFm Affordable Medicines Facility-malaria
AMRH African Medicines Regulatory Harmonization
APC advance purchase commitment
API active pharmaceutical ingredient
ARV antiretroviral
BMGF Bill & Melinda Gates Foundation
BRICS Brazil, Russia, India, China, and South Africa
CDC U.S. Centers for Disease Control and Prevention
CHAI Clinton Health Access Initiative
DOT directly observed treatment
DOTS Directly Observed Treatment-Short course
DR TB drug-resistant tuberculosis
DST drug susceptibility testing
EMA European Medicines Agency
EMR electronic medical record
FDA U.S. Food and Drug Administration
FLD first-line anti-TB drug

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement